These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6702649)

  • 1. Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion.
    Wolf RA; Glogar D; Chaung LY; Garrett PE; Ertl G; Tumas J; Braunwald E; Kloner RA; Feldstein ML; Muller JE
    Am J Cardiol; 1984 Mar; 53(7):941-4. PubMed ID: 6702649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term preservation of ischemic myocardium in the dog by hyaluronidase.
    Kloner RA; Braunwald E; Maroko PR
    Circulation; 1978 Aug; 58(2):220-6. PubMed ID: 668070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serum kinetics of bovine testicular hyaluronidase in dogs, rats and humans.
    Wolf RA; Chaung LY; O'Hara D; Smith TW; Muller JE
    J Pharmacol Exp Ther; 1982 Aug; 222(2):331-7. PubMed ID: 7097553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.
    DeBoer LW; Strauss HW; Kloner RA; Rude RE; Davis RF; Maroko PR; Braunwald E
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6119-23. PubMed ID: 6934538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog.
    Saliba MJ; Covell JW; Bloor CM
    Am J Cardiol; 1976 Mar; 37(4):599-604. PubMed ID: 1258797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog.
    Darsee JR; Kloner RA; Braunwald E
    J Clin Invest; 1981 Jul; 68(1):225-39. PubMed ID: 7019244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.
    Maclean D; Fishbein MC; Braunwald E; Maroko PR
    J Clin Invest; 1978 Mar; 61(3):541-51. PubMed ID: 641137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ortho-iodo sodium benzoate on acute myocardial ischemia, hemodynamic function, and infarct size after coronary artery occlusion in dogs.
    Rude RE; Tumas J; Gunst M; Kloner RA; DeBoer LW; Maroko PR
    Am J Cardiol; 1983 May; 51(8):1422-7. PubMed ID: 6846170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of xamoterol, a beta 1-adrenoceptor partial agonist, on myocardial pH decreased by coronary occlusion in dogs.
    Sashida H; Sakai K; Hino T; Abiko Y
    Pharmacology; 1986; 33(6):301-10. PubMed ID: 2882527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early disappearance of lymphatics draining ischemic myocardium in the dog.
    Szlavy L; Koster K; de Courten A; Hollenberg NK
    Angiology; 1987 Jan; 38(1 Pt 2):73-84. PubMed ID: 3813124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
    Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
    Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of epicardial R wave voltage following experimental coronary artery occlusion: effects of hyaluronidase.
    Ribeiro LG; Hillis LD; Maroko PR
    Cardiovasc Res; 1981 Aug; 15(8):425-9. PubMed ID: 7307026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion.
    Maroko PR; Libby P; Bloor CM; Sobel BE; Braunwald E
    Circulation; 1972 Sep; 46(3):430-7. PubMed ID: 5071733
    [No Abstract]   [Full Text] [Related]  

  • 14. A method for demonstrating the efficacy of interventions designed to limit infarct size following coronary occlusion: beneficial effect of hyaluronidase.
    Riberio LG; Hillis LD; Louie EK; Davis MA; Maroko PR; Braunwald E
    Cardiovasc Res; 1978 Jun; 12(6):334-40. PubMed ID: 698985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependency of location of salvageable myocardium on type of intervention.
    Darsee JR; Kloner RA
    Am J Cardiol; 1981 Oct; 48(4):702-10. PubMed ID: 7282552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs.
    Hillis LD; Fishbein MC; Braunwald E; Maroko PR
    Circ Res; 1977 Jul; 41(1):26-31. PubMed ID: 862139
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation of myocardial salvage to size of myocardium at risk in dogs.
    Zalewski A; Goldberg S; Faria DB; Krol R; Maroko PR
    Am J Cardiol; 1985 Dec; 56(15):974-7. PubMed ID: 4072932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hyaluronidase on reducing myocardial infarct size in a baboon model of ischemia-reperfusion injury.
    Premaratne S; Watanabe BI; LaPenna WF; McNamara JJ
    J Surg Res; 1995 Feb; 58(2):205-10. PubMed ID: 7861774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.
    Beller GA; Conroy J; Smith TW
    J Clin Invest; 1976 Feb; 57(2):341-50. PubMed ID: 130383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLS 2210, hyaluronidase and the cardiac lymphatic system.
    Szlavy L; Kubik S; de Courten A; Hachen HJ; Solti F
    Angiology; 1985 Jul; 36(7):452-7. PubMed ID: 3839639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.